Status:

RECRUITING

Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload

Lead Sponsor:

Johannes Grand

Conditions:

Acute Heart Failure

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Aim to identify the best strategy for treating acute heart failure (AHF) with volume overload, particularly focusing on patients resistant to standard loop-diuretics. The trial is a double-blinded, ra...

Detailed Description

Trial synopsis Title: OPTIMAL DIURETIC THERAPIES FOR ACUTE HEART FAILURE WITH VOLUME OVERLOAD - A RANDOMIZED CLINICAL TRIAL Background: Intravenous loop-diuretics have been the key component in trea...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Acute hospital admission with a clinical diagnosis of acute heart failure with volume overload.
  • Display risk of diuretic resistance, characterized by:
  • Daily loop-diuretics administration for a minimum of 7 days before admission, or
  • Insufficient decongestion observed in the preceding 24 hours (weight reduction \<500g or negative fluid balance \<1L) despite being treated with high-dose IV loop diuretic (equivalent to ≥120 mg IV furosemide within 24 hours).
  • Clinical signs of congestion, indicated by one or more of the following: pitting peripheral edema, ascites, elevated jugular venous pressure, or radiological/ultrasonic evidence of pulmonary congestion.

Exclusion

  • Acute coronary syndrome
  • Systolic blood pressure \<85 mmHg
  • Use of renal replacement therapy or ultrafiltration in-hospital before study inclusion
  • Treatment with acetazolamide or metolazone during the index hospitalization prior to randomization
  • Known allergy to any of the used drugs
  • Severe hypokalemia (\<2.5 mmol/l) or severe hyponatremia (\<125 mmol/l)
  • Severe hepatic impairment or liver cirrhosis
  • Known pregnancy

Key Trial Info

Start Date :

September 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2027

Estimated Enrollment :

939 Patients enrolled

Trial Details

Trial ID

NCT06166654

Start Date

September 5 2024

End Date

September 30 2027

Last Update

February 20 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Amager-Hvidovre Hospital

Hvidovre, Capital Region of Denmark, Denmark, 2650

2

Bispebjerg Hospital

Copenhagen, Denmark, 2400

3

Herlev-Gentofte hospital

Copenhagen, Denmark, 2730